LAG3 and ovarian carcinoma: For example, Huang and colleagues demonstrated in an ovarian cancer mouse model that the inhibition of PD-1 by a monoclonal antibody led to the compensatory upregulation of other immune checkpoints, such as LAG-3 or CTLA-4 [14].